IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2017

Selective Inhibitors of Vitamin D Metabolism – New Concepts and Perspectives.
I. SCHUSTER, H. EGGER, G. HERZIG, G.S. REDDY, J.A. SCHMID, M. SCHÜSSLER, G. VORISEK (Vienna, Austria; Providence, RI, USA). Anticancer Res 26: 2653-2668, 2006.
Effects of 1—,25-Dihydroxyvitamin D3 in Human Colon Cancer Cells.
J.M. GONZÁLEZ- SANCHO, M.J. LARRIBA, P. ORDÓÑEZ-MORÁN, H.G. PÁLMER, A. MUÑOZ (Madrid, Spain; London, UK). Anticancer Res 26: 2669-2682, 2006.
Vitamin D Analogs and Coactivators.
G. EELEN, L. VERLINDEN, P. DE CLERCQ, M. VANDEWALLE, R. BOUILLON, A. VERSTUYF (Leuven; Gent, Belgium). Anticancer Res 26: 2717-2722, 2006.
UV Radiation and Cancer Prevention: What is the Evidence?
R. KRAUSE, B. MATULLA- NOLTE, M. ESSERS, A. BROWN, W. HOPFEN MÜLLER (Berlin, Germany). Anticancer Res 26: 2723-2728, 2006.
Cutaneous Photosynthesis of Vitamin D: An Evolutionary Highly-conserved Endocrine System that Protects against Environmental Hazards Including UV-radiation and Microbial Infections.
L. TREMEZAYGUES, M. STICHERLING, C. PFÖHLER, M. FRIEDRICH, V. MEINEKE, M. SEIFERT, W. TILGEN, J. REICHRATH (Homburg/Saar; Leipzig; Lübeck; München, Germany). Anticancer Res 26: 2743-2748, 2006.
Role of Surgery in Treatment of Locally Advanced Prostate Cancer.
D. PREZIOSO, R. GALASSO, M. DI MARTINO, G. IAPICCA, F. IACONO (Naples, Italy). Anticancer Res 26: 3151- 3158, 2006.
Proteomics in the Diagnosis of Hepatocellular Carcinoma: Focus on High Risk Hepatitis B and C Patients.
A. EL-ANEED, J. BANOUB (St. John’s, NL, Canada). Anticancer Res 26: 3293- 3300, 2006.
New Molecular Mechanisms of Action of Camptothecin-type Drugs.
K. LEGARZA, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 26: 3301-3306, 2006.
Recent Progress in Target Therapy in Colorectal Cancer.
L.M. PASETTO, A. BORTOLAMI, C. FALCI, G. SINIGAGLIA, S. MONFARDINI (Padova; Aviano, Italy). Anticancer Res 26: 3973- 3982, 2006.
The Therapeutic Potential of Immuno-cell Therapy of Cancer in Combination with Aminobisphosphonates.
S. GOTO, A. NOGUCHI, H. JINGUJI, M. TAKAHARA (Tokyo, Japan). Anticancer Res 26: 3989-3996, 2006.
Unique Molecular Characteristics of the Environmental Responses of Mucosal Macrophages.
K. NAKATA, H. INAGAWA, T. NISHIZAWA, C. KOHCHI, Y. TANIGUCHI, N. YOSHIOKA, G.-I. SOMA (Tokushima; Shimonoseki; Chiba, Japan). Anticancer Res 26: 4009- 4014, 2006.
Possible Applications of Antibodies or their Genes in Cancer Therapy.
M. KUROKI, J. HUANG, H. SHIBAGUCHI, T. TANAKA, J. ZHAO, N. LUO, K. HACHIMINE, T. KINUGASA, S.-I. MAEKAWA, S. ENATSU, W. HAMANAKA, T. FUKAMI, M. KUROKI (Fukuoka, Japan). Anticancer Res 26: 4019- 4026, 2006.
HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer.
K.M. AHMED, N. CAO, J.J. LI (West Lafayette, IN, USA). Anticancer Res 26: 4235-4244, 2006.
The Emerging World of MicroRNAs.
L. O’DRISCOLL (Dublin, Ireland). Anticancer Res 26: 4271- 4278, 2006.
Anticancer Potential of Silymarin: From Bench to Bed Side.
R. AGARWAL, C. AGARWAL, H. ICHIKAWA, R.P. SINGH, B.B. AGGARWAL (Denver, CO; Houston, TX, USA). Anticancer Res 26: 4457-4498, 2006.
Hepatic Metastases of Colorectal Cancer: Locoregional Intra-arterial Treatment.
L.M. PASETTO, R. MERENDA, P. PILATI, G. SINIGAGLIA, S. MONFARDINI (Padova, Italy). Anticancer Res 26: 4785-4792, 2006.
Ovarian Cancer Screening.
M. KYRGIOU, I. TSOUMPOU, P. MARTIN-HIRSCH, M. ARBYN, W. PRENDIVILLE, G. KOLIOPOULOS, N. DALKALITSIS, P. STAMATOPOULOS, E. PARASKEVAIDIS (London; Edinburgh; Preston; Oxford, UK; Brussels, Belgium; Lyon, France; Dublin, Ireland; Ioannina; Thessaloniki, Greece). Anticancer Res 26: 4793-4802, 2006.
Parathyroid Cancer: Etiology, Clinical Presentation and Treatment.
F. LUMACHI, S.M.M. BASSO, U. BASSO (Padova, Italy). Anticancer Res 26: 4803-4808, 2006.
Adjuvant Chemotherapy for Colon Cancer.
A.G. PALLIS, I.A. MOUZAS (Heraklion, Greece). Anticancer Res 26: 4809-4816, 2006.
B-cell Differentiation, Apoptosis and Proliferation in Diffuse Large B-cell Lymphomas.
M. BAI, A. SKYRLAS, N.J. AGNANTIS, S. KAMINA, A. PAPOUDOU-BAI, P. KITSOULIS, P. KANAVAROS (Ioannina, Greece). Anticancer Res 25: 347-362, 2005.
Prostate Cancer Therapy: Standard Management, New Options and Experimental Approaches.
L. TROJAN, K. KIKNAVELIDZE, T. KNOLL, P. ALKEN, M.S. MICHEL (Mannheim, Germany). Anticancer Res 25: 551-562, 2005.
FOLFOX Versus FOLFIRI: A Comparison of Regimens in the Treatment of Colorectal Cancer Metastases.
L.M. PASETTO, A. JIRILLO, G. IADICICCO, E. ROSSI, M.K. PARIS, S. MONFARDINI (Padova, Italy). Anticancer Res 25: 563-576, 2005.
Molecular Genetic Tumor Markers in Non-small Cell Lung Cancer.
Antibody Therapy for Breast Cancer.
A. WILLEMS, K. GAUGER, C. HENRICHS, N. HARBECK (Munich, Germany). Anticancer Res 25: 1483-1490, 2005.
Current Approaches in Chemotherapy of Advanced and Metastatic Non-small Cell Lung Cancer (NSCLC).
M. RECK (Grosshansdorf, Germany). Anticancer Res 25: 1501-1506, 2005.
The MLL Gene and Translocations Involving Chromosomal Band 11q23 in Acute Leukemia.
M. DE BRAEKELEER, F. MOREL, M.-J. LE BRIS, A. HERRY, N. DOUET-GUILBERT (Brest, France). Anticancer Res 25: 1931-1944, 2005.
Nuclear Phospholipase C Signaling Through Type 1 IGF Receptor and its Involvement in Cell Growth and Differentiation.
I. FAENZA, A.M. BILLI, M. YUNG FOLLO, R. FIUME, A.M. MARTELLI, L. COCCO, L. MANZOLI (Bologna, Italy). Anticancer Res 25: 2039-2042, 2005.
Pharmacokinetics of Therapeutic Monoclonal Antibodies Used in Oncology.
D. LEVΚQUE, S. WISNIEWSKI, F. JEHL (Strasbourg, France). Anticancer Res 25: 2327-2344, 2005.
Contemporary Definitions of Tumor Specific Antigens, Immunogens and Markers as Related to the Adaptive Responses of the Cancer-bearing Host.
J.H. COGGIN JR., A.L. BARSOUM, J.W. ROHRER, M. THURNHER, M. ZEIS (Mobile, AL, USA; Innsbruck, Austria; Hamburg, Germany). Anticancer Res 25: 2345-2356, 2005.
Phytoestrogens in Cancer Prevention and Therapy – Mechanisms of their Biological Activity.
J. WIETRZYK, G. GRYNKIEWICZ, A. OPOLSKI (Wroclaw; Warsaw; Czestochowa, Poland). Anticancer Res 25: 2357-2366, 2005.
A Practical Overview of Aromatase Inhibitors.
J. YOUNUS, T.A. VANDENBERG (London, Ont., Canada). Anticancer Res 25: 2497-2502, 2005.
Murine Polyomavirus Virus-like Particles (VLPs) as Vectors for Gene and Immune Therapy and Vaccines against Viral Infections and Cancer.
K. TEGERSTEDT, A. VLASTOS FRANZΙN, K. ANDREASSON, J. JONEBERG, S. HEIDARI, T. RAMQVIST, T. DALIANIS (Stockholm, Sweden). Anticancer Res 25: 2601-2608, 2005.
The Elastin Connection and Melanoma Progression.
W. HORNEBECK, A. ROBINET, L. DUCA, F. ANTONICELLI, J. WALLACH, G. BELLON (Reims; Lyon, France). Anticancer Res 25: 2617-2626, 2005.
Prostate Cancer and Inositol Hexaphosphate: Efficacy and Mechanisms.
R.P. SINGH, R. AGARWAL (Denver, CO, USA). Anticancer Res 25: 2891-2904, 2005.
Impact of Cytogenetic and Molecular Cytogenetic Studies on Hematologic Malignancies.
A. KOLIALEXI, G.TH. TSANGARIS, S. KITSIOU, E. KANAVAKIS, A. MAVROU (Athens, Greece). Anticancer Res 25: 2979-2984, 2005.
Telomere Attrition as Ageing Biomarker.
S. BEKAERT, T. DE MEYER, P. VAN OOSTVELDT (Ghent, Belgium). Anticancer Res 25: 3011-3022, 2005.
The Biological Role of Smoking, Oral Contraceptive Use and Endogenous Sexual Steroid Hormones in Invasive Squamous Epithelial Cervical Cancer.
D. HELLBERG, U. STENDAHL (Falun; Uppsala; Umea, Sweden). Anticancer Res 25: 3041-3046, 2005.
Progress in Molecular Mechanisms of Tumor Metastasis and Angiogenesis.
A. HARLOZINSKA (Wroclaw, Poland). Anticancer Res 25: 3327-3334, 2005.
Clinical Experience with Bevacizumabn in Colorectal Cancer.
N. SALESI, G. BOSSONE, E. VELTRI, B. DI COCCO, P. MAROLLA, U. PACETTI, G. LAROSA, R. MUNI, A. VECCHIONE (Terracina; Rome, Italy). Anticancer Res 25: 3619-3624, 2005.
Multiple Roles of Cyclooxygenase-2 in Endometrial Cancer.
S. OHNO, Y. OHNO, N. SUZUKI, H. INAGAWA, C. KOHCHI, G.-I. SOMA, M. INOUE (Osaka; Ishikawa; Yamaguchi; Tokushima; Chiba, Japan). Anticancer Res 25: 3679-3688, 2005.
Gc Protein (Vitamin D-binding Protein): Gc Genotyping and GcMAF Precursor Activity.
H. NAGASAWA, Y. UTO, H. SASAKI, N. OKAMURA, A. MURAKAMI, S. KUBO, K.L. KIRK, H. HORI (Tokushima, Japan; Bethesda, MD, USA). Anticancer Res 25: 3689-3696, 2005.
Re-targeting of Cytotoxic T Lymphocytes and/or Natural Killer Cells to CEA-expressing Tumor Cells with Anti-CEA Antibody Activity.
M. KUROKI, K. HACHIMINE, J. HUANG, H. SHIBAGUCHI, T. KINUGASA, S.-I. MAEKAWA, M. KUROKI (Fukuoka, Japan). Anticancer Res 25: 3725-3732, 2005.
Tumor Endothelial Cells are Targets for Selective Therapies: In Vitro and In Vivo Models to Evaluate Antiangiogenic Strategies.
A. DUTOUR, M. RIGAUD (Houston, TX, USA; Limoges, France). Anticancer Res 25: 3799-3808, 2005.
Nuclear Matrix Protein Expression in Prostate Cancer: Possible Prognostic and Diagnostic Applications.
P. BARBORO, A. RUBAGOTTI, F. BOCCARDO, B. CARNEMOLLA, C. D’ARRIGO, E. PATRONE, C. BALBI (Genoa, Italy). Anticancer Res 25: 3999-4004, 2005.
Lymphangiogenesis, Inflammation and Metastasis.
S.F. SCHOPPMANN (Vienna, Austria). Anticancer Res 25: 4503-4512, 2005.
Biological Prognostic Factors in Adult Soft Tissue Sarcomas.
A. OTTAIANO, A. DE CHIARA, F. FAZIOLI, A. AIELLO TALAMANCA, S. MORI, GERARDO BOTTI, A. MILANO, G. APICE (Naples, Italy). Anticancer Res 25: 4519-4526, 2005.
Prostate Cancer in the Elderly.
K.N. SYRIGOS, E. KARAPANAGIOTOU, K.J. HARRINGTON (Athens, Greece; London, UK). Anticancer Res 25: 4527-4534, 2005.
Perspectives of Immunotherapy in Metastatic Breast Cancer.
D. LÜFTNER, D. POLLMANN, S. SCHILDHAUER, J. SEHOULI, K. POSSINGER (Berlin, Germany). Anticancer Res 25: 4599-4604, 2005.
Page: 1 2 3 4 5 6 ... 7 8 9 10 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system